Protoporphyrin IX in serum of glioblastoma patients after 5-ALA administration – a potential biomarker?

• A. Walke,
• C. Krone,
• S. Hellwig,
• M. Müther,
• W. Stummer,
• S. König,
• E. Suero-Molina

Affiliations

A. Walke

University Hospital of Münster, Neurosurgery, Münster, Germany; Core Unit Proteomics, Interdisciplinary Center for Clinical Research, Münster, Germany

C. Krone

University Hospital of Münster, Neurosurgery, Münster, Germany

S. Hellwig

University Hospital of Münster, Neurosurgery, Münster, Germany

M. Müther

University Hospital of Münster, Neurosurgery, Münster, Germany

W. Stummer

University Hospital of Münster, Neurosurgery, Münster, Germany

S. König

Core Unit Proteomics, Interdisciplinary Center for Clinical Research, Münster, Germany

E. Suero-Molina

University Hospital of Münster, Neurosurgery, Münster, Germany